CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: phenytoin
Accession: CHEBI:8107
browse the term
Definition: A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5.
Synonyms: related_synonym: 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-diphenylimidazolidine-2,4-dione; 5,5-diphenyltetrahydro-1H-2,4-imidazoledione; DILANTIN; Formula=C15H12N2O2; InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19); InChIKey=CXOFVDLJLONNDW-UHFFFAOYSA-N; PHENTYTOIN; SMILES=O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1; fenitoina; phenytoine; phenytoinum
alt_id: CHEBI:100921
xref: Beilstein:384532; CAS:57-41-0; DrugBank:DB00252; Drug_Central:2152; HMDB:HMDB0014397; KEGG:C07443; KEGG:D00512; LINCS:LSM-5663
xref_mesh: MESH:D010672
xref: PMID:10698828; PMID:12952753; PMID:15246836; PMID:15744730; PMID:16303054; PMID:7105825; PMID:7602118; PMID:9186244; Patent:WO2012174723; Reaxys:384532; Wikipedia:Phenytoin
G
AAAS
aladin WD repeat nucleoporin
decreases expression
ISO
Phenytoin results in decreased expression of AAAS mRNA
CTD
PMID:20345932
NCBI chr12:53,307,460...53,321,610
Ensembl chr12:53,307,456...53,324,864
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
ISO
Phenytoin results in decreased expression of ABCA1 mRNA
CTD
PMID:15136057
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB1
ATP binding cassette subfamily B member 1
affects response to substance multiple interactions increases expression increases transport affects abundance decreases activity increases metabolic processing
EXP ISO
ABCB1 protein affects the susceptibility to Phenytoin Amino Acids, Peptides, and Proteins inhibits the reaction [Phenytoin results in increased expression of ABCB1 protein]; Phenytoin results in increased expression of and results in increased activity of ABCB1A protein ABCB1A protein results in increased transport of Phenytoin ABCB1 protein affects the abundance of Phenytoin Phenytoin results in decreased activity of ABCB1 protein ABCB1 protein results in increased metabolism of Phenytoin
CTD
PMID:8001500 PMID:10580886 PMID:14749549 PMID:15569486 PMID:16220110 PMID:17045309 PMID:17376120 PMID:17529887 PMID:18408562 PMID:18440557 PMID:18473823 More...
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
multiple interactions increases expression
ISO
KN 62 inhibits the reaction [Phenytoin results in increased expression of ABCC1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Phenytoin results in increased expression of ABCC1 protein]
CTD
PMID:18473823
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC2
ATP binding cassette subfamily C member 2
affects transport multiple interactions increases expression affects response to substance
ISO EXP
ABCC2 protein affects the transport of Phenytoin KN 62 inhibits the reaction [Phenytoin results in increased expression of ABCC2 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Phenytoin results in increased expression of ABCC2 protein] ABCC2 protein affects the susceptibility to Phenytoin
CTD
PMID:12663688 PMID:14636316 PMID:17376120 PMID:18473823
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
increases expression
ISO
Phenytoin results in increased expression of ABCC3 mRNA
CTD
PMID:17381134
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCG1
ATP binding cassette subfamily G member 1
decreases expression
ISO
Phenytoin results in decreased expression of ABCG1 mRNA
CTD
PMID:15136057
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
G
ABHD5
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase
increases expression
ISO
Phenytoin results in increased expression of ABHD5 mRNA
CTD
PMID:20345932
NCBI chr 3:43,690,870...43,734,371
Ensembl chr 3:43,690,108...43,734,371
G
ABLIM1
actin binding LIM protein 1
decreases expression
ISO
Phenytoin results in decreased expression of ABLIM1 mRNA
CTD
PMID:15136057
NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,112...114,768,061
G
ACE2
angiotensin converting enzyme 2
decreases expression
EXP
Phenytoin results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACHE
acetylcholinesterase (Yt blood group)
increases activity
ISO
Phenytoin results in increased activity of ACHE protein
CTD
PMID:16946593
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ADAM8
ADAM metallopeptidase domain 8
decreases expression
EXP
Phenytoin results in decreased expression of ADAM8 mRNA
CTD
PMID:14741686
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAMTS9
ADAM metallopeptidase with thrombospondin type 1 motif 9
increases expression
ISO
Phenytoin results in increased expression of ADAMTS9 mRNA
CTD
PMID:20345932
NCBI chr 3:64,515,654...64,688,000
Ensembl chr 3:64,515,654...64,688,000
G
ADGRB3
adhesion G protein-coupled receptor B3
increases expression
ISO
Phenytoin results in increased expression of ADGRB3 mRNA
CTD
PMID:20345932
NCBI chr 6:68,635,282...69,389,506
Ensembl chr 6:68,635,282...69,390,571
G
ADRB3
adrenoceptor beta 3
decreases expression
ISO
Phenytoin results in decreased expression of ADRB3 mRNA
CTD
PMID:20345932
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
AFP
alpha fetoprotein
decreases expression
EXP ISO
Phenytoin results in decreased expression of AFP mRNA
CTD
PMID:14741686 PMID:26272751
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
G
AGAP3
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
decreases expression
ISO
Phenytoin results in decreased expression of AGAP3 mRNA
CTD
PMID:20345932
NCBI chr 7:151,085,867...151,144,434
Ensembl chr 7:151,085,831...151,144,436
G
AHR
aryl hydrocarbon receptor
multiple interactions increases expression
ISO
CYP3A11 protein affects the reaction [Phenytoin results in increased expression of AHR mRNA] Ketoconazole inhibits the reaction [Phenytoin results in increased expression of AHR protein]
CTD
PMID:17505019
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AKAP10
A-kinase anchoring protein 10
increases expression
ISO
Phenytoin results in increased expression of AKAP10 mRNA
CTD
PMID:20345932
NCBI chr17:19,904,302...19,977,828
Ensembl chr17:19,904,302...19,978,343
G
AKR7A3
aldo-keto reductase family 7 member A3
decreases expression increases expression
ISO
Phenytoin results in decreased expression of AKR7A3 mRNA Phenytoin results in increased expression of AKR7A3 mRNA
CTD
PMID:17381134
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
increases expression
ISO
Phenytoin results in increased expression of ALDH1A1 mRNA
CTD
PMID:17381134
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ALDH1A2
aldehyde dehydrogenase 1 family member A2
decreases expression
EXP
Phenytoin results in decreased expression of ALDH1A2 mRNA
CTD
PMID:31711903
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
G
AMN1
antagonist of mitotic exit network 1 homolog
increases expression
ISO
Phenytoin results in increased expression of AMN1 mRNA
CTD
PMID:20345932
NCBI chr12:31,671,137...31,729,174
Ensembl chr12:31,671,142...31,729,121
G
ANXA4
annexin A4
increases expression
EXP
Phenytoin results in increased expression of ANXA4 mRNA
CTD
PMID:14741686
NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
G
ANXA5
annexin A5
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA
CTD
PMID:21224054
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
APOA1
apolipoprotein A1
increases expression
ISO
Phenytoin results in increased expression of APOA1 mRNA
CTD
PMID:15136057
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOA4
apolipoprotein A4
increases expression
ISO
Phenytoin results in increased expression of APOA4 mRNA
CTD
PMID:15136057
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOE
apolipoprotein E
increases expression
ISO
Phenytoin results in increased expression of APOE mRNA
CTD
PMID:15136057
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
AR
androgen receptor
multiple interactions increases expression increases activity
ISO
[Phenytoin co-treated with Prednisolone] results in increased expression of AR protein Phenytoin results in increased expression of AR protein Ketoconazole inhibits the reaction [Phenytoin results in increased expression of AR protein] Phenytoin results in increased expression of AR mRNA; Phenytoin results in increased expression of AR protein Phenytoin results in increased activity of AR protein
CTD
PMID:19226368 PMID:19490052
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARFIP1
ADP ribosylation factor interacting protein 1
increases expression
ISO
Phenytoin results in increased expression of ARFIP1 mRNA
CTD
PMID:20345932
NCBI chr 4:152,779,954...152,912,357
Ensembl chr 4:152,779,937...152,918,463
G
ARHGAP39
Rho GTPase activating protein 39
increases expression
ISO
Phenytoin results in increased expression of ARHGAP39 mRNA
CTD
PMID:20345932
NCBI chr 8:144,529,179...144,700,362
Ensembl chr 8:144,529,179...144,685,846
G
ARMC8
armadillo repeat containing 8
increases expression
ISO
Phenytoin results in increased expression of ARMC8 mRNA
CTD
PMID:20345932
NCBI chr 3:138,187,248...138,298,389
Ensembl chr 3:138,187,248...138,298,384
G
ATM
ATM serine/threonine kinase
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM protein
CTD
PMID:21224054
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
ATPAF1
ATP synthase mitochondrial F1 complex assembly factor 1
decreases expression
ISO
Phenytoin results in decreased expression of ATPAF1 mRNA
CTD
PMID:20345932
NCBI chr 1:46,632,737...46,668,557
Ensembl chr 1:46,632,737...46,673,867
G
B4GALT7
beta-1,4-galactosyltransferase 7
decreases expression
ISO
Phenytoin results in decreased expression of B4GALT7 mRNA
CTD
PMID:20345932
NCBI chr 5:177,600,132...177,610,330
Ensembl chr 5:177,600,132...177,610,330
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA
CTD
PMID:21224054
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
multiple interactions decreases expression
EXP ISO
Phenytoin results in increased expression of and affects the localization of BCL2 protein Phenytoin results in decreased expression of BCL2 mRNA
CTD
PMID:9118846 PMID:10695937
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA
CTD
PMID:21224054
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BMP1
bone morphogenetic protein 1
decreases expression
EXP
Phenytoin results in decreased expression of BMP1 mRNA
CTD
PMID:14741686
NCBI chr 8:22,165,372...22,212,326
Ensembl chr 8:22,165,140...22,212,326
G
BMP4
bone morphogenetic protein 4
increases expression
ISO
Phenytoin results in increased expression of BMP4 mRNA
CTD
PMID:16141649
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
C2
complement C2
decreases expression
ISO
Phenytoin results in decreased expression of C2 mRNA
CTD
PMID:20345932
NCBI chr 6:31,897,783...31,945,672
Ensembl chr 6:31,897,785...31,945,673
G
CA6
carbonic anhydrase 6
increases expression
ISO
Phenytoin results in increased expression of CAR6 mRNA
CTD
PMID:20345932
NCBI chr 1:8,945,868...8,975,092
Ensembl chr 1:8,945,867...8,975,092
G
CACYBP
calcyclin binding protein
increases expression
ISO
Phenytoin results in increased expression of CACYBP mRNA
CTD
PMID:20345932
NCBI chr 1:174,999,435...175,012,027
Ensembl chr 1:174,999,163...175,012,027
G
CALCA
calcitonin related polypeptide alpha
decreases expression
ISO
Phenytoin results in decreased expression of CALCA protein
CTD
PMID:2470235
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
G
CALM2
calmodulin 2
decreases expression
EXP
Phenytoin results in decreased expression of CALM2 mRNA
CTD
PMID:14741686
NCBI chr 2:47,160,082...47,176,936
Ensembl chr 2:47,160,084...47,176,921
G
CAPN5
calpain 5
decreases expression
EXP
Phenytoin results in decreased expression of CAPN5 mRNA
CTD
PMID:14741686
NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155
G
CASKIN1
CASK interacting protein 1
affects expression
ISO
Phenytoin affects the expression of CASKIN1 mRNA
CTD
PMID:20345932
NCBI chr16:2,177,180...2,196,605
Ensembl chr16:2,177,180...2,196,605
G
CASP10
caspase 10
increases expression
EXP
Phenytoin results in increased expression of CASP10 mRNA
CTD
PMID:14741686
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
G
CAT
catalase
decreases response to substance
EXP
CAT protein results in decreased susceptibility to Phenytoin
CTD
PMID:21252394
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CBLL1
Cbl proto-oncogene like 1
increases expression
ISO
Phenytoin results in increased expression of CBLL1 mRNA
CTD
PMID:20345932
NCBI chr 7:107,744,142...107,761,667
Ensembl chr 7:107,743,073...107,761,667
G
CCL2
C-C motif chemokine ligand 2
increases expression
ISO
Phenytoin results in increased expression of CCL2 protein
CTD
PMID:14578793
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCNC
cyclin C
increases expression
ISO
Phenytoin results in increased expression of CCNC mRNA
CTD
PMID:20345932
NCBI chr 6:99,542,387...99,568,814
Ensembl chr 6:99,542,387...99,568,825
G
CCND1
cyclin D1
multiple interactions decreases expression
ISO EXP
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CCND1 mRNA Phenytoin results in decreased expression of CCND1 mRNA
CTD
PMID:14741686 PMID:21224054
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCNG1
cyclin G1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CCNG1 mRNA
CTD
PMID:21224054
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CD47
CD47 molecule
decreases expression
ISO
Phenytoin results in decreased expression of CD47 mRNA
CTD
PMID:17381134
NCBI chr 3:108,043,091...108,091,031
Ensembl chr 3:108,043,091...108,091,862
G
CDH2
cadherin 2
decreases expression
ISO
Phenytoin results in decreased expression of CDH2 mRNA
CTD
PMID:9118846
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CDK1
cyclin dependent kinase 1
decreases expression
ISO
Phenytoin results in decreased expression of CDK1 mRNA
CTD
PMID:26272751
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDKN1A
cyclin dependent kinase inhibitor 1A
decreases expression multiple interactions
EXP ISO
Phenytoin results in decreased expression of CDKN1A mRNA [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A protein
CTD
PMID:14741686 PMID:21224054
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDX2
caudal type homeobox 2
increases expression
ISO
Phenytoin results in increased expression of CDX2 mRNA
CTD
PMID:20345932
NCBI chr13:27,960,918...27,969,315
Ensembl chr13:27,960,918...27,969,315
G
CELA2A
chymotrypsin like elastase 2A
decreases expression
EXP
Phenytoin results in decreased expression of CELA2A mRNA
CTD
PMID:14741686
NCBI chr 1:15,456,732...15,472,091
Ensembl chr 1:15,456,728...15,472,091
G
CEP57
centrosomal protein 57
increases expression
ISO
Phenytoin results in increased expression of CEP57 mRNA
CTD
PMID:20345932
NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693
G
CER1
cerberus 1, DAN family BMP antagonist
decreases expression
ISO
Phenytoin results in decreased expression of CER1 mRNA
CTD
PMID:26272751
NCBI chr 9:14,717,326...14,722,733
Ensembl chr 9:14,719,724...14,722,733
G
CHEK2
checkpoint kinase 2
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CHEK2 mRNA
CTD
PMID:21224054
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
G
CKM
creatine kinase, M-type
increases expression
EXP
Phenytoin results in increased expression of CKM protein
CTD
PMID:6682525
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
G
CLCN6
chloride voltage-gated channel 6
decreases expression
ISO
Phenytoin results in decreased expression of CLCN6 mRNA
CTD
PMID:20345932
NCBI chr 1:11,806,191...11,843,130
Ensembl chr 1:11,806,096...11,848,079
G
CMPK1
cytidine/uridine monophosphate kinase 1
increases expression
ISO
Phenytoin results in increased expression of CMPK1 mRNA
CTD
PMID:20345932
NCBI chr 1:47,333,790...47,378,839
Ensembl chr 1:47,333,790...47,394,866
G
CNOT7
CCR4-NOT transcription complex subunit 7
increases expression
ISO
Phenytoin results in increased expression of CNOT7 mRNA
CTD
PMID:20345932
NCBI chr 8:17,224,966...17,246,857
Ensembl chr 8:17,224,966...17,246,878
G
COL11A1
collagen type XI alpha 1 chain
increases expression
EXP
Phenytoin results in increased expression of COL11A1 mRNA
CTD
PMID:14741686
NCBI chr 1:102,876,473...103,108,522
Ensembl chr 1:102,876,467...103,108,872
G
COL18A1
collagen type XVIII alpha 1 chain
decreases expression
EXP
Phenytoin results in decreased expression of COL18A1 mRNA
CTD
PMID:14741686
NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
G
COL1A1
collagen type I alpha 1 chain
multiple interactions increases expression decreases expression
EXP
Phenytoin inhibits the reaction [IL1B protein results in decreased expression of COL1A1 mRNA] Phenytoin results in increased expression of COL1A1 mRNA Phenytoin results in decreased expression of COL1A1 mRNA
CTD
PMID:8971655 PMID:14741686
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL1A2
collagen type I alpha 2 chain
increases expression affects expression
EXP ISO
Phenytoin results in increased expression of COL1A2 mRNA Phenytoin affects the expression of COL1A2 mRNA
CTD
PMID:14741686 PMID:24704097
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
G
COL6A1
collagen type VI alpha 1 chain
decreases expression increases expression
EXP
Phenytoin results in decreased expression of COL6A1 mRNA Phenytoin results in increased expression of COL6A1 mRNA
CTD
PMID:8224229 PMID:14741686
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
G
COL6A2
collagen type VI alpha 2 chain
increases expression
EXP
Phenytoin results in increased expression of COL6A2 mRNA
CTD
PMID:8224229
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
G
COL6A3
collagen type VI alpha 3 chain
increases expression
EXP
Phenytoin results in increased expression of COL6A3 mRNA
CTD
PMID:8224229
NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
G
CP
ceruloplasmin
decreases expression
ISO
Phenytoin results in decreased expression of CP mRNA
CTD
PMID:17381134
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CPSF6
cleavage and polyadenylation specific factor 6
increases expression
ISO
Phenytoin results in increased expression of CPSF6 mRNA
CTD
PMID:20345932
NCBI chr12:69,239,569...69,274,358
Ensembl chr12:69,239,569...69,274,358
G
CRH
corticotropin releasing hormone
affects expression
ISO
Phenytoin affects the expression of CRH mRNA
CTD
PMID:20345932
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CRPPA
CDP-L-ribitol pyrophosphorylase A
increases expression
ISO
Phenytoin results in increased expression of CRPPA mRNA
CTD
PMID:20345932
NCBI chr 7:16,087,525...16,421,538
Ensembl chr 7:16,087,525...16,502,504
G
CTSB
cathepsin B
increases expression decreases activity
EXP
Phenytoin results in increased expression of CTSB mRNA Phenytoin results in decreased activity of CTSB protein
CTD
PMID:10914799 PMID:14741686
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSL
cathepsin L
decreases activity increases expression
EXP
Phenytoin results in decreased activity of CTSL protein Phenytoin results in increased expression of CTSL mRNA
CTD
PMID:10914799
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CUL4A
cullin 4A
increases expression
ISO
Phenytoin results in increased expression of CUL4A mRNA
CTD
PMID:20345932
NCBI chr13:113,208,193...113,267,108
Ensembl chr13:113,208,193...113,267,108
G
CX3CL1
C-X3-C motif chemokine ligand 1
increases expression
ISO
Phenytoin results in increased expression of CX3CL1 mRNA
CTD
PMID:20345932
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA
CTD
PMID:21224054
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of CXCL2 mRNA; Alprostadil inhibits the reaction [[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of CXCL2 mRNA]
CTD
PMID:23986454
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
decreases activity
EXP
Phenytoin results in decreased activity of CYP19A1 protein
CTD
PMID:17959350
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
increases expression
ISO EXP
Phenytoin results in increased expression of CYP1A1 mRNA
CTD
PMID:9860486 PMID:17381134
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
EXP
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin
CTD
PMID:23397584
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA
CTD
PMID:21224054
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2A5 mRNA
CTD
PMID:21224054
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions decreases expression increases expression increases activity
EXP ISO
[Phenytoin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]]]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]; NOC 18 inhibits the reaction [Phenytoin results in increased expression of CYP2B6 protein]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of and results in increased activity of CYP2B6 protein]; NR1I2 protein promotes the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]; NR1I3 protein affects the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]; Phenytoin results in increased expression of and results in increased activity of CYP2B6 protein; pimagedine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] Phenytoin results in decreased expression of CYP2B10 protein [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA Phenytoin results in increased expression of CYP2B6 mRNA; Phenytoin results in increased expression of CYP2B6 protein Phenytoin results in increased activity of CYP2B6 protein
CTD
PMID:12571232 PMID:12695351 PMID:14977870 PMID:15123723 PMID:17041008 PMID:17954527 PMID:18206661 PMID:18332078 PMID:19226368 PMID:21224054 PMID:21924250 PMID:23850985 PMID:28289823 More...
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases hydroxylation increases metabolic processing multiple interactions decreases metabolic processing increases hydroxylation affects metabolic processing
EXP ISO
CYP2C19 gene polymorphism results in decreased hydroxylation of Phenytoin CYP2C19 protein results in increased metabolism of Phenytoin [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin CYP2C19 gene polymorphism results in decreased metabolism of Phenytoin CYP2C19 protein results in increased hydroxylation of Phenytoin CYP2C19 protein affects the metabolism of Phenytoin
CTD
PMID:9146858 PMID:9333104 PMID:9579299 PMID:9860067 PMID:15569425 PMID:15855726 PMID:16220110 PMID:16789993 PMID:18511451 PMID:23397584 More...
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
affects expression multiple interactions increases expression
ISO
Phenytoin affects the expression of CYP2C29 mRNA [Phenytoin results in decreased activity of CYP2C29 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde; NR1I3 protein affects the reaction [Phenytoin results in increased expression of CYP2C29 mRNA] Phenytoin results in increased expression of CYP2C protein; Phenytoin results in increased expression of CYP2C29 mRNA; Phenytoin results in increased expression of CYP2C29 protein
CTD
PMID:12051692 PMID:15155833 PMID:19136022 PMID:19903449 PMID:21766881
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
multiple interactions increases metabolic processing increases activity increases hydroxylation decreases metabolic processing decreases hydroxylation increases expression increases response to substance affects metabolic processing
EXP
[Clozapine results in decreased activity of CYP2C9 protein] which results in increased susceptibility to Phenytoin; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin; [CYP2C9 protein results in increased hydroxylation of Phenytoin] which results in increased abundance of hydroxyphenytoin; Miconazole inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Phenytoin] which results in increased abundance of hydroxyphenytoin]; Miconazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Phenytoin]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of CYP2C9 mRNA] CYP2C9 protein results in increased metabolism of Phenytoin Phenytoin results in increased activity of CYP2C9 protein CYP2C9 5' UTR polymorphism results in decreased metabolism of Phenytoin; CYP2C9 gene polymorphism results in decreased metabolism of Phenytoin CYP2C9 gene polymorphism results in decreased hydroxylation of Phenytoin CYP2C9 gene polymorphism results in increased susceptibility to Phenytoin CYP2C9 protein affects the metabolism of Phenytoin; CYP2C9 protein alternative form affects the metabolism of Phenytoin
CTD
PMID:2025243 PMID:9110362 PMID:9860067 PMID:10208645 PMID:10510154 PMID:10850388 PMID:11234294 PMID:11434505 PMID:11503012 PMID:11668218 PMID:11740344 PMID:14600250 PMID:14659971 PMID:15855726 PMID:16220110 PMID:16873909 PMID:17961958 PMID:19082874 PMID:19202563 PMID:19715737 PMID:20405111 PMID:23397584 PMID:27163851 PMID:33961833 More...
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
multiple interactions
EXP
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin
CTD
PMID:23397584
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions decreases expression increases expression
EXP ISO
NOC 18 inhibits the reaction [Phenytoin results in increased expression of CYP2E1 mRNA] Phenytoin results in decreased expression of CYP2E1 mRNA Phenytoin results in increased expression of CYP2E1 mRNA; Phenytoin results in increased expression of CYP2E1 protein
CTD
PMID:17381134 PMID:18206661
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions increases expression increases activity
EXP ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Phenytoin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; NOC 18 inhibits the reaction [Phenytoin results in increased expression of CYP3A4 mRNA]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of CYP3A4 mRNA]; NR3C1 protein promotes the reaction [Phenytoin results in increased expression of CYP3A4 mRNA]; Phenytoin promotes the reaction [CYP3A4 protein results in increased hydroxylation of Cholecalciferol]; Phenytoin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA] Phenytoin results in increased expression of CYP3A2 mRNA; Phenytoin results in increased expression of CYP3A2 protein Ketoconazole inhibits the reaction [Phenytoin results in increased expression of CYP3A2 protein] Phenytoin results in increased activity of CYP3A4 protein Phenytoin results in increased expression of CYP3A4 mRNA; Phenytoin results in increased expression of CYP3A4 protein
CTD
PMID:9512926 PMID:10219967 PMID:12065438 PMID:12505310 PMID:12673034 PMID:12695340 PMID:14977870 PMID:15466163 PMID:16207822 PMID:16837568 PMID:17505019 PMID:17954527 PMID:18206661 PMID:18332078 PMID:19226368 PMID:21402137 PMID:21742782 PMID:23397584 PMID:28289823 More...
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
increases expression
EXP ISO
Phenytoin results in increased expression of CYP3A5 mRNA Phenytoin results in increased expression of CYP3A13 mRNA
CTD
PMID:12673034 PMID:19903449
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
increases expression
EXP ISO
Phenytoin results in increased expression of CYP3A7 mRNA Phenytoin results in increased expression of CYP3A13 mRNA
CTD
PMID:12673034 PMID:19903449
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP4A22
cytochrome P450 family 4 subfamily A member 22
decreases expression
ISO
Phenytoin results in decreased expression of CYP4A1 mRNA
CTD
PMID:17381134
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA
CTD
PMID:21224054
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
increases expression
ISO
Phenytoin results in increased expression of CYP7B1 mRNA
CTD
PMID:20345932
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
DAP3
death associated protein 3
increases expression
EXP
Phenytoin results in increased expression of DAP3 mRNA
CTD
PMID:14741686
NCBI chr 1:155,687,948...155,739,010
Ensembl chr 1:155,687,960...155,739,010
G
DAPK2
death associated protein kinase 2
decreases expression
EXP
Phenytoin results in decreased expression of DAPK2 mRNA
CTD
PMID:14741686
NCBI chr15:63,907,036...64,046,485
Ensembl chr15:63,907,036...64,072,033
G
DDIT3
DNA damage inducible transcript 3
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of DDIT3 mRNA
CTD
PMID:21224054
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DHX9
DExH-box helicase 9
increases expression
ISO
Phenytoin results in increased expression of DHX9 mRNA
CTD
PMID:20345932
NCBI chr 1:182,839,347...182,887,982
Ensembl chr 1:182,839,347...182,887,982
G
DMTN
dematin actin binding protein
decreases expression
ISO
Phenytoin results in decreased expression of DMTN mRNA
CTD
PMID:20345932
NCBI chr 8:22,048,931...22,082,525
Ensembl chr 8:22,048,995...22,082,527
G
DNAJA1
DnaJ heat shock protein family (Hsp40) member A1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of DNAJA1 mRNA
CTD
PMID:21224054
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
G
E2F1
E2F transcription factor 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of E2F1 mRNA
CTD
PMID:21224054
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
EBPL
EBP like
increases expression
ISO
Phenytoin results in increased expression of EBPL mRNA
CTD
PMID:20345932
NCBI chr13:49,660,674...49,691,487
Ensembl chr13:49,660,674...49,691,486
G
EGR1
early growth response 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA
CTD
PMID:21224054
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR3
early growth response 3
increases expression
ISO
Phenytoin results in increased expression of EGR3 mRNA
CTD
PMID:20345932
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
G
EMX2
empty spiracles homeobox 2
decreases expression
ISO
Phenytoin results in decreased expression of EMX2 mRNA
CTD
PMID:9118846
NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
G
ENPEP
glutamyl aminopeptidase
decreases expression increases expression
ISO
Phenytoin results in decreased expression of ENPEP mRNA Phenytoin results in increased expression of ENPEP mRNA
CTD
PMID:17381134
NCBI chr 4:110,476,155...110,565,285
Ensembl chr 4:110,365,733...110,565,285
G
EOMES
eomesodermin
increases expression
EXP
Phenytoin results in increased expression of EOMES mRNA
CTD
PMID:14741686
NCBI chr 3:27,715,953...27,722,713
Ensembl chr 3:27,715,949...27,722,711
G
EPHX1
epoxide hydrolase 1
affects response to substance increases expression
EXP ISO
EPHX1 gene polymorphism affects the susceptibility to Phenytoin Phenytoin results in increased expression of EPHX1 mRNA
CTD
PMID:17381134 PMID:19952982
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPHX2
epoxide hydrolase 2
decreases expression
ISO
Phenytoin results in decreased expression of EPHX2 mRNA
CTD
PMID:17381134
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ESR1
estrogen receptor 1
increases expression
ISO
Phenytoin results in increased expression of ESR1 mRNA; Phenytoin results in increased expression of ESR1 protein
CTD
PMID:19490052
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
EYA1
EYA transcriptional coactivator and phosphatase 1
decreases expression
EXP
Phenytoin results in decreased expression of EYA1 mRNA
CTD
PMID:31711903
NCBI chr 8:71,197,433...71,548,094
Ensembl chr 8:71,197,433...71,592,025
G
F10
coagulation factor X
decreases expression
ISO
Phenytoin results in decreased expression of F10 mRNA
CTD
PMID:17381134
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
F2
coagulation factor II, thrombin
multiple interactions
EXP
[clobazam co-treated with Phenytoin] results in increased expression of [F2 protein binds to SERPINC1 protein]
CTD
PMID:16376047
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FASLG
Fas ligand
multiple interactions decreases expression
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA; [Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of FASL mRNA Phenytoin results in decreased expression of FASL mRNA
CTD
PMID:21224054 PMID:23986454
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FBXL3
F-box and leucine rich repeat protein 3
increases expression
ISO
Phenytoin results in increased expression of FBXL3 mRNA
CTD
PMID:20345932
NCBI chr13:77,005,260...77,027,159
Ensembl chr13:76,992,598...77,027,195
G
FBXO30
F-box protein 30
increases expression
ISO
Phenytoin results in increased expression of FBXO30 mRNA
CTD
PMID:20345932
NCBI chr 6:145,793,502...145,814,795
Ensembl chr 6:145,793,502...145,814,795
G
FGF12
fibroblast growth factor 12
increases expression
ISO
Phenytoin results in increased expression of FGF12 mRNA
CTD
PMID:20345932
NCBI chr 3:192,139,390...192,727,541
Ensembl chr 3:192,139,390...192,767,764
G
FGF5
fibroblast growth factor 5
increases expression
EXP
Phenytoin results in increased expression of FGF5 mRNA
CTD
PMID:14741686
NCBI chr 4:80,266,588...80,291,017
Ensembl chr 4:80,266,639...80,336,680
G
FGF8
fibroblast growth factor 8
increases expression
EXP
Phenytoin results in increased expression of FGF8 mRNA
CTD
PMID:31711903
NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371
G
FGF9
fibroblast growth factor 9
increases expression
EXP
Phenytoin results in increased expression of FGF9 mRNA
CTD
PMID:14741686
NCBI chr13:21,671,073...21,704,498
Ensembl chr13:21,671,073...21,704,498
G
FGFR2
fibroblast growth factor receptor 2
increases expression
EXP
Phenytoin results in increased expression of FGFR2 mRNA; Phenytoin results in increased expression of FGFR2 protein
CTD
PMID:11352631
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FLRT2
fibronectin leucine rich transmembrane protein 2
increases expression
EXP
Phenytoin results in increased expression of FLRT2 mRNA
CTD
PMID:14741686
NCBI chr14:85,530,144...85,654,428
Ensembl chr14:85,530,144...85,654,428
G
FMO1
flavin containing dimethylaniline monoxygenase 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA
CTD
PMID:21224054
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
G
FMO4
flavin containing dimethylaniline monoxygenase 4
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA
CTD
PMID:21224054
NCBI chr 1:171,314,183...171,342,084
Ensembl chr 1:171,314,183...171,342,084
G
FMOD
fibromodulin
decreases expression
EXP
Phenytoin results in decreased expression of FMOD mRNA
CTD
PMID:14741686
NCBI chr 1:203,340,628...203,351,122
Ensembl chr 1:203,340,628...203,351,758
G
FMR1
fragile X messenger ribonucleoprotein 1
increases expression
ISO
Phenytoin results in increased expression of FMR1 mRNA
CTD
PMID:20345932
NCBI chr X:147,911,919...147,951,125
Ensembl chr X:147,911,919...147,951,125
G
FN1
fibronectin 1
increases expression
EXP
Phenytoin results in increased expression of FN1 mRNA
CTD
PMID:14741686
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FNDC3A
fibronectin type III domain containing 3A
increases expression
ISO
Phenytoin results in increased expression of FNDC3A mRNA
CTD
PMID:20345932
NCBI chr13:48,975,291...49,209,779
Ensembl chr13:48,975,912...49,209,779
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Drugs, Chinese Herbal] inhibits the reaction [Kainic Acid results in increased expression of FOS mRNA] Phenytoin results in decreased expression of FOS protein
CTD
PMID:7789465 PMID:8758711
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOXC2
forkhead box C2
decreases expression
EXP
Phenytoin results in decreased expression of FOXC2 mRNA
CTD
PMID:31711903
NCBI chr16:86,566,829...86,569,728
Ensembl chr16:86,566,829...86,569,728
G
FOXP3
forkhead box P3
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of FOXP3 mRNA Phenytoin results in decreased expression of FOXP3 mRNA
CTD
PMID:23986454
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
FRS3
fibroblast growth factor receptor substrate 3
decreases expression
EXP
Phenytoin results in decreased expression of FRS3 mRNA
CTD
PMID:14741686
NCBI chr 6:41,770,176...41,779,900
Ensembl chr 6:41,770,176...41,786,542
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
Phenytoin results in decreased expression of G6PC1 mRNA
CTD
PMID:17381134
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
G6PD
glucose-6-phosphate dehydrogenase
affects response to substance
ISO
G6PDX protein affects the susceptibility to Phenytoin
CTD
PMID:10627286
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GADD45A
growth arrest and DNA damage inducible alpha
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GADD45A mRNA
CTD
PMID:21224054
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GATA3
GATA binding protein 3
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of GATA3 mRNA Phenytoin results in decreased expression of GATA3 mRNA
CTD
PMID:23986454
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
ISO
Phenytoin results in increased expression of GCLM mRNA
CTD
PMID:20345932
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GLUL
glutamate-ammonia ligase
decreases activity
ISO
Phenytoin results in decreased activity of GLUL protein
CTD
PMID:10323596
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
G
GNL2
G protein nucleolar 2
increases expression
ISO
Phenytoin results in increased expression of GNL2 mRNA
CTD
PMID:20345932
NCBI chr 1:37,566,816...37,595,937
Ensembl chr 1:37,566,816...37,595,937
G
GNPDA2
glucosamine-6-phosphate deaminase 2
increases expression
ISO
Phenytoin results in increased expression of GNPDA2 mRNA
CTD
PMID:20345932
NCBI chr 4:44,701,795...44,726,556
Ensembl chr 4:44,682,200...44,726,588
G
GPM6A
glycoprotein M6A
increases expression
ISO
Phenytoin results in increased expression of GPM6A mRNA
CTD
PMID:20345932
NCBI chr 4:175,632,937...176,002,691
Ensembl chr 4:175,632,934...176,002,664
G
GPX2
glutathione peroxidase 2
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA
CTD
PMID:21224054
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
increases expression
ISO
Phenytoin results in increased expression of GRIN1 mRNA
CTD
PMID:20345932
NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
G
GSTA1
glutathione S-transferase alpha 1
increases expression
EXP
Phenytoin results in increased expression of GSTA1 mRNA
CTD
PMID:11134551
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTA2
glutathione S-transferase alpha 2
increases expression decreases expression
ISO
Phenytoin results in increased expression of GSTA2 mRNA Phenytoin results in decreased expression of GSTA2 mRNA
CTD
PMID:17381134
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTK1
glutathione S-transferase kappa 1
decreases expression
EXP
Phenytoin results in decreased expression of GSTK1 mRNA
CTD
PMID:14741686
NCBI chr 7:143,263,441...143,269,115
Ensembl chr 7:143,244,093...143,270,854
G
GSTM1
glutathione S-transferase mu 1
increases expression multiple interactions
ISO
Phenytoin results in increased expression of GSTM1 mRNA [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein
CTD
PMID:17381134 PMID:21224054
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM2
glutathione S-transferase mu 2
increases expression
ISO
Phenytoin results in increased expression of GSTM2 mRNA
CTD
PMID:17381134
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM3
glutathione S-transferase mu 3
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA
CTD
PMID:21224054
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GSTO1
glutathione S-transferase omega 1
decreases expression
EXP
Phenytoin results in decreased expression of GSTO1 mRNA
CTD
PMID:14741686
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
GUSB
glucuronidase beta
multiple interactions decreases activity
ISO
Phenytoin inhibits the reaction [Misonidazole results in increased activity of GUSB protein] Phenytoin results in decreased activity of GUSB protein
CTD
PMID:6696821
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
G
HDAC7
histone deacetylase 7
increases expression
ISO
Phenytoin results in increased expression of HDAC7 mRNA
CTD
PMID:26272751
NCBI chr12:47,782,722...47,821,344
Ensembl chr12:47,782,722...47,833,132
G
HELZ
helicase with zinc finger
increases expression
ISO
Phenytoin results in increased expression of HELZ mRNA
CTD
PMID:20345932
NCBI chr17:67,070,444...67,245,989
Ensembl chr17:67,070,444...67,245,989
G
HEXIM1
HEXIM P-TEFb complex subunit 1
increases expression
ISO
Phenytoin results in increased expression of HEXIM1 mRNA
CTD
PMID:20345932
NCBI chr17:45,148,475...45,152,099
Ensembl chr17:45,148,475...45,152,099
G
HLA-B
major histocompatibility complex, class I, B
affects response to substance
EXP
HLA-B gene polymorphism affects the susceptibility to Phenytoin
CTD
PMID:20235791
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HMGB1
high mobility group box 1
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased secretion of HMGB1 protein
CTD
PMID:23986454
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMOX1
heme oxygenase 1
multiple interactions increases expression
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HMOX1 mRNA Phenytoin results in increased expression of HMOX1 mRNA
CTD
PMID:17381134 PMID:21224054
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
ISO
Phenytoin results in increased expression of HNRNPA2B1 mRNA
CTD
PMID:20345932
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
G
HOOK3
hook microtubule tethering protein 3
increases expression
ISO
Phenytoin results in increased expression of HOOK3 mRNA
CTD
PMID:20345932
NCBI chr 8:42,896,978...43,030,535
Ensembl chr 8:42,896,946...43,030,535
G
HOXA2
homeobox A2
decreases expression
ISO
Phenytoin results in decreased expression of HOXA2 mRNA; Phenytoin results in decreased expression of HOXA2 protein
CTD
PMID:10789828
NCBI chr 7:27,100,354...27,102,683
Ensembl chr 7:27,100,354...27,102,686
G
HOXB7
homeobox B7
increases expression
EXP
Phenytoin results in increased expression of HOXB7 mRNA
CTD
PMID:31711903
NCBI chr17:48,607,232...48,611,017
Ensembl chr17:48,607,232...48,633,572
G
HOXB9
homeobox B9
increases expression
EXP
Phenytoin results in increased expression of HOXB9 mRNA
CTD
PMID:31711903
NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
G
HSPA1L
heat shock protein family A (Hsp70) member 1 like
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA
CTD
PMID:21224054
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
G
HSPA8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA
CTD
PMID:21224054
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HSPB1
heat shock protein family B (small) member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPB1 mRNA
CTD
PMID:21224054
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
G
HSPD1
heat shock protein family D (Hsp60) member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPD1 mRNA
CTD
PMID:21224054
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HSPE1
heat shock protein family E (Hsp10) member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPE1 mRNA
CTD
PMID:21224054
NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
G
IFNG
interferon gamma
decreases expression
ISO
Phenytoin results in decreased expression of IFNG protein
CTD
PMID:10982153
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IFNGR1
interferon gamma receptor 1
increases expression
EXP
Phenytoin results in increased expression of IFNGR1 mRNA
CTD
PMID:14741686
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IFNGR2
interferon gamma receptor 2
increases expression
EXP
Phenytoin results in increased expression of IFNGR2 mRNA
CTD
PMID:14741686
NCBI chr21:33,402,882...33,437,516
Ensembl chr21:33,403,413...33,479,348
G
IGF1
insulin like growth factor 1
decreases expression
ISO
Phenytoin results in decreased expression of IGF1 mRNA
CTD
PMID:17381134
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF2
insulin like growth factor 2
increases expression
ISO
Phenytoin results in increased expression of IGF2 mRNA
CTD
PMID:9988880
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IHH
Indian hedgehog signaling molecule
increases expression
ISO
Phenytoin results in increased expression of IHH mRNA
CTD
PMID:16141649
NCBI chr 2:219,054,424...219,060,921
Ensembl chr 2:219,054,424...219,060,921
G
IL17A
interleukin 17A
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased secretion of IL17A protein
CTD
PMID:23986454
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL18 mRNA
CTD
PMID:21224054
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
multiple interactions
EXP ISO
Phenytoin inhibits the reaction [IL1B protein results in decreased expression of COL1A1 mRNA] [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL1B mRNA; [Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of IL1B mRNA; [Phenytoin co-treated with Buthionine Sulfoximine] results in increased secretion of IL1B protein
CTD
PMID:8971655 PMID:21224054 PMID:23986454
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL23A
interleukin 23 subunit alpha
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of IL23A mRNA
CTD
PMID:23986454
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL6
interleukin 6
multiple interactions increases expression
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of IL6 mRNA; [Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of IL6 mRNA Phenytoin results in increased expression of IL6 mRNA
CTD
PMID:21224054 PMID:23986454
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
decreases expression
ISO
Phenytoin results in decreased expression of IL6RA mRNA
CTD
PMID:15136057
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
INPP5F
inositol polyphosphate-5-phosphatase F
increases expression
ISO
Phenytoin results in increased expression of INPP5F mRNA
CTD
PMID:20345932
NCBI chr10:119,726,050...119,829,147
Ensembl chr10:119,726,042...119,829,147
G
INSR
insulin receptor
increases expression
EXP
Phenytoin results in increased expression of INSR mRNA
CTD
PMID:14741686
NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
G
IPP
intracisternal A particle-promoted polypeptide
increases expression
ISO
Phenytoin results in increased expression of IPP mRNA
CTD
PMID:20345932
NCBI chr 1:45,694,324...45,750,653
Ensembl chr 1:45,694,324...45,750,653
G
IRF9
interferon regulatory factor 9
increases expression
ISO
Phenytoin results in increased expression of IRF9 mRNA
CTD
PMID:20345932
NCBI chr14:24,161,265...24,166,565
Ensembl chr14:24,161,234...24,168,043
G
ITGA2
integrin subunit alpha 2
decreases expression
EXP
Phenytoin results in decreased expression of ITGA2 protein
CTD
PMID:15948689
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA8
integrin subunit alpha 8
increases expression
EXP
Phenytoin results in increased expression of ITGA8 mRNA
CTD
PMID:14741686
NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,922
G
ITGB1
integrin subunit beta 1
decreases expression
EXP
Phenytoin results in decreased expression of ITGB1 protein
CTD
PMID:15948689
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
ITGB3BP
integrin subunit beta 3 binding protein
increases expression
ISO
Phenytoin results in increased expression of ITGB3BP mRNA
CTD
PMID:20345932
NCBI chr 1:63,440,770...63,529,187
Ensembl chr 1:63,440,770...63,593,721
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Phenytoin results in decreased expression of JUN mRNA
CTD
PMID:9118846
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KCND2
potassium voltage-gated channel subfamily D member 2
increases expression
ISO
Phenytoin results in increased expression of KCND2 mRNA
CTD
PMID:20345932
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
G
KCNH2
potassium voltage-gated channel subfamily H member 2
decreases activity
EXP
Phenytoin results in decreased activity of KCNH2 protein
CTD
PMID:21158687
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
KCTD3
potassium channel tetramerization domain containing 3
increases expression
ISO
Phenytoin results in increased expression of KCTD3 mRNA
CTD
PMID:20345932
NCBI chr 1:215,567,304...215,621,807
Ensembl chr 1:215,567,304...215,621,807
G
KDR
kinase insert domain receptor
increases expression
ISO
Phenytoin results in increased expression of KDR mRNA
CTD
PMID:26272751
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
KHDRBS2
KH RNA binding domain containing, signal transduction associated 2
increases expression
ISO
Phenytoin results in increased expression of KHDRBS2 mRNA
CTD
PMID:20345932
NCBI chr 6:61,542,670...62,286,225
Ensembl chr 6:61,679,961...62,286,225
G
KLF2
KLF transcription factor 2
increases expression
ISO
Phenytoin results in increased expression of KLF2 mRNA
CTD
PMID:20345932
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
G
KLHL2
kelch like family member 2
increases expression
ISO
Phenytoin results in increased expression of KLHL2 mRNA
CTD
PMID:20345932
NCBI chr 4:165,207,561...165,323,156
Ensembl chr 4:165,207,561...165,323,156
G
KLHL7
kelch like family member 7
increases expression
ISO
Phenytoin results in increased expression of KLHL7 mRNA
CTD
PMID:20345932
NCBI chr 7:23,105,785...23,177,914
Ensembl chr 7:23,105,758...23,177,914
G
KRIT1
KRIT1 ankyrin repeat containing
increases expression
ISO
Phenytoin results in increased expression of KRIT1 mRNA
CTD
PMID:20345932
NCBI chr 7:92,198,969...92,246,100
Ensembl chr 7:92,197,498...92,246,166
G
KRT2
keratin 2
increases expression
EXP
Phenytoin results in increased expression of KRT2 mRNA
CTD
PMID:14741686
NCBI chr12:52,644,558...52,652,211
Ensembl chr12:52,644,558...52,652,211
G
KYAT1
kynurenine aminotransferase 1
increases activity
ISO
Phenytoin results in increased activity of KYAT1 protein
CTD
PMID:16765940
NCBI chr 9:128,832,942...128,882,523
Ensembl chr 9:128,832,942...128,882,494 Ensembl chr 9:128,832,942...128,882,494
G
LAMA2
laminin subunit alpha 2
increases expression
ISO
Phenytoin results in increased expression of LAMA2 mRNA
CTD
PMID:20345932
NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566
G
LAP3
leucine aminopeptidase 3
affects expression
ISO
Phenytoin affects the expression of LAP3 mRNA
CTD
PMID:20345932
NCBI chr 4:17,577,198...17,607,970
Ensembl chr 4:17,577,198...17,607,972
G
LCAT
lecithin-cholesterol acyltransferase
increases expression
ISO
Phenytoin results in increased expression of LCAT mRNA
CTD
PMID:15136057
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LDB2
LIM domain binding 2
increases expression
ISO
Phenytoin results in increased expression of LDB2 mRNA
CTD
PMID:20345932
NCBI chr 4:16,501,541...16,898,645
Ensembl chr 4:16,501,541...16,898,678
G
LPIN1
lipin 1
increases expression
EXP
Phenytoin results in increased expression of LPIN1 mRNA
CTD
PMID:14741686
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
LRBA
LPS responsive beige-like anchor protein
increases expression
ISO
Phenytoin results in increased expression of LRBA mRNA
CTD
PMID:20345932
NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
G
LSM1
LSM1 homolog, mRNA degradation associated
decreases expression
ISO
Phenytoin results in decreased expression of LSM1 mRNA
CTD
PMID:20345932
NCBI chr 8:38,163,321...38,176,730
Ensembl chr 8:38,163,335...38,176,730
G
LTBP4
latent transforming growth factor beta binding protein 4
increases expression
ISO
Phenytoin results in increased expression of LTBP4 mRNA
CTD
PMID:20345932
NCBI chr19:40,593,166...40,629,820
Ensembl chr19:40,592,883...40,629,818
G
LYPLA1
lysophospholipase 1
increases expression
ISO
Phenytoin results in increased expression of LYPLA1 mRNA
CTD
PMID:20345932
NCBI chr 8:54,046,367...54,101,947
Ensembl chr 8:54,046,367...54,102,017
G
MAP1B
microtubule associated protein 1B
increases expression
EXP
Phenytoin results in increased expression of MAP1B mRNA
CTD
PMID:14741686
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
G
MAP3K4
mitogen-activated protein kinase kinase kinase 4
increases expression
ISO
Phenytoin results in increased expression of MAP3K4 mRNA
CTD
PMID:20345932
NCBI chr 6:160,991,769...161,117,380
Ensembl chr 6:160,991,727...161,117,385
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
Phenytoin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:15948689
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
EXP
Phenytoin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:15948689
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPRE3
microtubule associated protein RP/EB family member 3
increases expression
ISO
Phenytoin results in increased expression of MAPRE3 mRNA
CTD
PMID:20345932
NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
G
MBL1P
mannose binding lectin 1, pseudogene
decreases expression
ISO
Phenytoin results in decreased expression of MBL1 mRNA
CTD
PMID:17381134
NCBI chr10:79,920,178...79,923,119
Ensembl chr10:79,920,327...79,923,032 Ensembl chr10:79,920,327...79,923,032
G
MDK
midkine
increases expression
EXP
Phenytoin results in increased expression of MDK mRNA
CTD
PMID:14741686
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MDM2
MDM2 proto-oncogene
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA
CTD
PMID:21224054
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ME1
malic enzyme 1
increases expression
ISO
Phenytoin results in increased expression of ME1 mRNA
CTD
PMID:17381134
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MEOX1
mesenchyme homeobox 1
decreases expression
EXP
Phenytoin results in decreased expression of MEOX1 mRNA
CTD
PMID:31711903
NCBI chr17:43,640,389...43,661,922
Ensembl chr17:43,640,389...43,661,922
G
MESP1
mesoderm posterior bHLH transcription factor 1
increases expression
ISO
Phenytoin results in increased expression of MESP1 mRNA
CTD
PMID:26272751
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
G
MEX3D
mex-3 RNA binding family member D
increases expression
ISO
Phenytoin results in increased expression of MEX3D mRNA
CTD
PMID:20345932
NCBI chr19:1,554,672...1,568,325
Ensembl chr19:1,554,672...1,568,325
G
MGAT2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Phenytoin results in increased expression of MGAT2 mRNA
CTD
PMID:20345932
NCBI chr14:49,620,799...49,623,481
Ensembl chr14:49,620,799...49,623,481
G
MGMT
O-6-methylguanine-DNA methyltransferase
increases methylation
EXP
Phenytoin results in increased methylation of MGMT promoter
CTD
PMID:15949900
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MKI67
marker of proliferation Ki-67
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein
CTD
PMID:21224054
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MMP1
matrix metallopeptidase 1
decreases expression increases expression
EXP
Phenytoin results in decreased expression of MMP1 mRNA Phenytoin results in increased expression of MMP1 mRNA
CTD
PMID:10914799 PMID:14741686 PMID:15948689
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP2
matrix metallopeptidase 2
decreases expression
EXP
Phenytoin results in decreased expression of MMP2 mRNA
CTD
PMID:15948689
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP3
matrix metallopeptidase 3
decreases expression
EXP
Phenytoin results in decreased expression of MMP3 mRNA
CTD
PMID:15948689
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MRPS18C
mitochondrial ribosomal protein S18C
increases expression
ISO
Phenytoin results in increased expression of MRPS18C mRNA
CTD
PMID:20345932
NCBI chr 4:83,456,058...83,462,298
Ensembl chr 4:83,455,932...83,469,735
G
MTF2
metal response element binding transcription factor 2
increases expression
ISO
Phenytoin results in increased expression of MTF2 mRNA
CTD
PMID:20345932
NCBI chr 1:93,079,283...93,139,076
Ensembl chr 1:93,079,235...93,139,079
G
MTHFD1L
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like
increases expression
ISO
Phenytoin results in increased expression of MTHFD1L mRNA
CTD
PMID:20345932
NCBI chr 6:150,865,702...151,101,887
Ensembl chr 6:150,865,679...151,101,887
G
MTX2
metaxin 2
increases expression
ISO
Phenytoin results in increased expression of MTX2 mRNA
CTD
PMID:20345932
NCBI chr 2:176,269,442...176,338,025
Ensembl chr 2:176,269,395...176,338,025
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression decreases expression
EXP ISO
Phenytoin results in increased expression of MYC protein Phenytoin results in decreased expression of MYC mRNA
CTD
PMID:10695937 PMID:26272751
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYO1E
myosin IE
increases expression
ISO
Phenytoin results in increased expression of MYO1E mRNA
CTD
PMID:26272751
NCBI chr15:59,132,434...59,372,871
Ensembl chr15:59,132,434...59,372,871
G
NAP1L2
nucleosome assembly protein 1 like 2
affects expression
ISO
Phenytoin affects the expression of NAP1L2 mRNA
CTD
PMID:20345932
NCBI chr X:73,212,299...73,214,851
Ensembl chr X:73,212,299...73,214,851
G
NCAN
neurocan
increases expression
EXP
Phenytoin results in increased expression of NCAN mRNA
CTD
PMID:14741686
NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
G
NCL
nucleolin
decreases expression
ISO
Phenytoin results in decreased expression of NCL mRNA
CTD
PMID:17381134
NCBI chr 2:231,453,531...231,464,484
Ensembl chr 2:231,453,531...231,483,641
G
NCOA1
nuclear receptor coactivator 1
multiple interactions
EXP
Phenytoin promotes the reaction [NR1I3 protein modified form binds to NCOA1 protein]
CTD
PMID:21924250
NCBI chr 2:24,491,254...24,770,702
Ensembl chr 2:24,491,254...24,770,702
G
NELFA
negative elongation factor complex member A
decreases expression
ISO
Phenytoin results in decreased expression of NELFA mRNA
CTD
PMID:20345932
NCBI chr 4:1,982,723...2,008,974
Ensembl chr 4:1,982,717...2,041,903
G
NES
nestin
decreases expression
ISO
Phenytoin results in decreased expression of NES mRNA
CTD
PMID:26272751
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
G
NEUROG2
neurogenin 2
increases expression
EXP
Phenytoin results in increased expression of NEUROG2 mRNA
CTD
PMID:31711903
NCBI chr 4:112,513,516...112,516,180
Ensembl chr 4:112,513,516...112,516,180
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions increases expression
EXP
Phenytoin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased localization of and results in increased activity of NFKB1 protein] Phenytoin results in increased expression of NFKB1 mRNA
CTD
PMID:10700573 PMID:14741686
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
decreases degradation
EXP
Phenytoin results in decreased degradation of NFKBIA protein
CTD
PMID:15948689
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NGLY1
N-glycanase 1
increases expression
ISO
Phenytoin results in increased expression of NGLY1 mRNA
CTD
PMID:20345932
NCBI chr 3:25,718,944...25,790,039
Ensembl chr 3:25,718,944...25,790,039
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of NLRP3 mRNA
CTD
PMID:23986454
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA
CTD
PMID:21224054
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NPAS2
neuronal PAS domain protein 2
increases expression
ISO
Phenytoin results in increased expression of NPAS2 mRNA
CTD
PMID:20345932
NCBI chr 2:100,818,723...100,996,829
Ensembl chr 2:100,820,139...100,996,829
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Phenytoin results in increased expression of NQO1 mRNA
CTD
PMID:17381134
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1I2
nuclear receptor subfamily 1 group I member 2
multiple interactions affects activity increases expression increases activity
EXP ISO
Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]]]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Phenytoin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of and results in increased activity of CYP2B6 protein]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of CYP2C9 mRNA]; NR1I2 protein affects the reaction [Phenytoin results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]; Phenytoin binds to and results in increased activity of NR1I2 protein; Phenytoin promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA] Phenytoin affects the activity of NR1I2 protein Phenytoin results in increased expression of NR1I2 protein Phenytoin results in increased activity of NR1I2 protein
CTD
PMID:12065438 PMID:12695340 PMID:12695351 PMID:14600250 PMID:14977870 PMID:15039302 PMID:18473823 PMID:21402137 PMID:23611293 More...
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR1I3
nuclear receptor subfamily 1 group I member 3
multiple interactions increases expression increases activity increases localization
EXP ISO
[Phenytoin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; NR1I3 protein affects the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]; Phenytoin promotes the reaction [NR1I3 protein modified form binds to NCOA1 protein] Phenytoin results in increased expression of NR1I3 protein NR1I3 protein affects the reaction [Phenytoin results in increased expression of CYP2C29 mRNA]; NR1I3 protein affects the reaction [Phenytoin results in increased expression of CYP2C37 mRNA] Phenytoin results in increased localization of NR1I3 protein
CTD
PMID:15123723 PMID:15155833 PMID:15849716 PMID:16936065 PMID:17041008 PMID:18473823 PMID:21924250 More...
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
NR2F1
nuclear receptor subfamily 2 group F member 1
increases expression
ISO
Phenytoin results in increased expression of NR2F1 mRNA
CTD
PMID:20345932
NCBI chr 5:93,583,222...93,594,611
Ensembl chr 5:93,583,222...93,594,611
G
NR3C1
nuclear receptor subfamily 3 group C member 1
multiple interactions increases expression
EXP ISO
Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Phenytoin results in increased expression of CYP2B6 mRNA]]]; NR3C1 protein promotes the reaction [Phenytoin results in increased expression of CYP3A4 mRNA] Phenytoin results in increased expression of NR3C1 mRNA
CTD
PMID:10219967 PMID:12695351 PMID:20345932
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NRCAM
neuronal cell adhesion molecule
decreases expression
ISO
Phenytoin results in decreased expression of NRCAM mRNA
CTD
PMID:26272751
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
NSMCE3
NSE3 homolog, SMC5-SMC6 complex component
increases expression
ISO
Phenytoin results in increased expression of NSMCE3 mRNA
CTD
PMID:20345932
NCBI chr15:29,264,989...29,269,822
Ensembl chr15:29,264,989...29,269,822
G
NT5DC1
5'-nucleotidase domain containing 1
increases expression
ISO
Phenytoin results in increased expression of NT5DC1 mRNA
CTD
PMID:20345932
NCBI chr 6:116,100,853...116,249,497
Ensembl chr 6:116,100,851...116,249,497
G
NTF3
neurotrophin 3
decreases expression
ISO
Phenytoin results in decreased expression of NTF3 mRNA
CTD
PMID:7841657
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
G
NUP153
nucleoporin 153
increases expression
ISO
Phenytoin results in increased expression of NUP153 mRNA
CTD
PMID:20345932
NCBI chr 6:17,615,037...17,706,925
Ensembl chr 6:17,615,035...17,706,925
G
OLIG3
oligodendrocyte transcription factor 3
increases expression
EXP
Phenytoin results in increased expression of OLIG3 mRNA
CTD
PMID:31711903
NCBI chr 6:137,492,199...137,494,394
Ensembl chr 6:137,492,199...137,494,394
G
OPRM1
opioid receptor mu 1
multiple interactions
ISO
[cyprodime binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Phenytoin
CTD
PMID:7870991
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
decreases expression
ISO
Phenytoin results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:15136057
NCBI chr17:2,593,183...2,685,615
Ensembl chr17:2,593,210...2,685,615
G
PAFAH1B2
platelet activating factor acetylhydrolase 1b catalytic subunit 2
decreases expression
ISO
Phenytoin results in decreased expression of PAFAH1B2 mRNA
CTD
PMID:15136057
NCBI chr11:117,144,287...117,178,173
Ensembl chr11:117,144,284...117,176,894
G
PARD6G
par-6 family cell polarity regulator gamma
increases expression
ISO
Phenytoin results in increased expression of PARD6G mRNA
CTD
PMID:20345932
NCBI chr18:80,157,232...80,247,514
Ensembl chr18:80,157,232...80,247,514
G
PARG
poly(ADP-ribose) glycohydrolase
increases expression
ISO
Phenytoin results in increased expression of PARG mRNA
CTD
PMID:20345932
NCBI chr10:49,818,279...49,942,027
Ensembl chr10:49,818,279...49,970,203
G
PAX3
paired box 3
decreases expression
ISO EXP
Phenytoin results in decreased expression of PAX3 mRNA
CTD
PMID:9118846 PMID:31711903
NCBI chr 2:222,199,887...222,298,998
Ensembl chr 2:222,199,887...222,298,998
G
PAX6
paired box 6
increases expression
EXP
Phenytoin results in increased expression of PAX6 mRNA
CTD
PMID:31711903
NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961
G
PBX1
PBX homeobox 1
increases expression
ISO
Phenytoin results in increased expression of PBX1 mRNA
CTD
PMID:20345932
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
G
PCYOX1
prenylcysteine oxidase 1
increases expression
ISO
Phenytoin results in increased expression of PCYOX1 mRNA
CTD
PMID:20345932
NCBI chr 2:70,257,915...70,281,185
Ensembl chr 2:70,257,386...70,281,185
G
PDGFA
platelet derived growth factor subunit A
increases expression
EXP
Phenytoin results in increased expression of PDGFA mRNA
CTD
PMID:14741686
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDGFB
platelet derived growth factor subunit B
increases expression
ISO EXP
Phenytoin results in increased expression of PDGFB mRNA; Phenytoin results in increased expression of PDGFB protein
CTD
PMID:8463938 PMID:9029455 PMID:14741686
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PGRMC1
progesterone receptor membrane component 1
increases expression
ISO
Phenytoin results in increased expression of PGRMC1 mRNA
CTD
PMID:17381134
NCBI chr X:119,236,285...119,244,466
Ensembl chr X:119,236,245...119,244,466
G
PHF14
PHD finger protein 14
increases expression
ISO
Phenytoin results in increased expression of PHF14 mRNA
CTD
PMID:20345932
NCBI chr 7:10,973,872...11,169,618
Ensembl chr 7:10,973,336...11,169,623
G
PIP4K2A
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
increases expression
EXP
Phenytoin results in increased expression of PIP4K2A mRNA
CTD
PMID:14741686
NCBI chr10:22,534,854...22,714,578
Ensembl chr10:22,534,854...22,714,578
G
PLAUR
plasminogen activator, urokinase receptor
decreases expression
EXP
Phenytoin results in decreased expression of PLAUR mRNA
CTD
PMID:14741686
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLCL1
phospholipase C like 1 (inactive)
increases expression
ISO
Phenytoin results in increased expression of PLCL1 mRNA
CTD
PMID:20345932
NCBI chr 2:197,804,593...198,149,863
Ensembl chr 2:197,804,593...198,572,581
G
PLEC
plectin
increases expression
ISO
Phenytoin results in increased expression of PLEC mRNA
CTD
PMID:20345932
NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,153...143,976,734
G
PLTP
phospholipid transfer protein
increases expression
ISO
Phenytoin results in increased expression of PLTP mRNA
CTD
PMID:15136057
NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,155
G
PLXNB2
plexin B2
decreases expression
EXP
Phenytoin results in decreased expression of PLXNB2 mRNA
CTD
PMID:14741686
NCBI chr22:50,274,979...50,307,646
Ensembl chr22:50,274,979...50,307,646
G
PNN
pinin, desmosome associated protein
increases expression
ISO
Phenytoin results in increased expression of PNN mRNA
CTD
PMID:20345932
NCBI chr14:39,175,254...39,183,220
Ensembl chr14:39,175,183...39,183,220
G
PON1
paraoxonase 1
decreases expression affects activity
ISO EXP
Phenytoin results in decreased expression of PON1 mRNA Phenytoin affects the activity of PON1 protein
CTD
PMID:15136057 PMID:28032682
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
POR
cytochrome p450 oxidoreductase
increases activity
ISO
Phenytoin results in increased activity of POR protein
CTD
PMID:12051692
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
POU3F1
POU class 3 homeobox 1
increases expression
ISO
Phenytoin results in increased expression of POU3F1 protein
CTD
PMID:12781989
NCBI chr 1:38,043,829...38,046,793
Ensembl chr 1:38,043,829...38,046,793
G
PPIL4
peptidylprolyl isomerase like 4
increases expression
ISO
Phenytoin results in increased expression of PPIL4 mRNA
CTD
PMID:20345932
NCBI chr 6:149,504,495...149,546,043
Ensembl chr 6:149,504,495...149,546,043
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of ATM protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CCND1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CHEK2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2A5 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP4A10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP4A14 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of DNAJA1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPD1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of HSPE1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL18 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of IL1B mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of RAD50 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TRADD mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of XRCC4 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CCNG1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CDKN1A protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP3A11 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP3A4 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of DDIT3 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of E2F1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GADD45A mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HMOX1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPB1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of IL6 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of SERPINE1 mRNA; [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of UNG mRNA; PRKDC gene mutant form results in increased susceptibility to [Rifampin co-treated with Phenytoin co-treated with Monocrotaline]
CTD
PMID:21224054
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
PRL
prolactin
decreases expression
ISO
Phenytoin results in decreased expression of PRL mRNA; Phenytoin results in decreased expression of PRL protein
CTD
PMID:3734668
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PRMT3
protein arginine methyltransferase 3
increases expression
ISO
Phenytoin results in increased expression of PRMT3 mRNA
CTD
PMID:20345932
NCBI chr11:20,387,716...20,509,338
Ensembl chr11:20,387,558...20,509,338
G
PRSS12
serine protease 12
increases expression
EXP
Phenytoin results in increased expression of PRSS12 mRNA
CTD
PMID:14741686
NCBI chr 4:118,280,038...118,353,003
Ensembl chr 4:118,280,038...118,353,003
G
PSIP1
PC4 and SRSF1 interacting protein 1
increases expression
ISO
Phenytoin results in increased expression of PSIP1 mRNA
CTD
PMID:20345932
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
G
PSMC6
proteasome 26S subunit, ATPase 6
increases expression
ISO
Phenytoin results in increased expression of PSMC6 mRNA
CTD
PMID:20345932
NCBI chr14:52,707,200...52,728,590
Ensembl chr14:52,707,178...52,728,590
G
PSMD12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
Phenytoin results in increased expression of PSMD12 mRNA
CTD
PMID:20345932
NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605
G
PTBP2
polypyrimidine tract binding protein 2
increases expression
ISO
Phenytoin results in increased expression of PTBP2 mRNA
CTD
PMID:20345932
NCBI chr 1:96,721,784...96,823,739
Ensembl chr 1:96,721,665...96,823,738
G
PTCH1
patched 1
increases expression
ISO
Phenytoin results in increased expression of PTCH1 mRNA
CTD
PMID:16141649
NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Phenytoin results in increased expression of PTGS2 mRNA
CTD
PMID:20345932
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTH
parathyroid hormone
increases expression
EXP
Phenytoin results in increased expression of PTH protein
CTD
PMID:20683115
NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181
G
RAD50
RAD50 double strand break repair protein
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of RAD50 mRNA
CTD
PMID:21224054
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RAI1
retinoic acid induced 1
increases expression
ISO
Phenytoin results in increased expression of RAI1 mRNA
CTD
PMID:20345932
NCBI chr17:17,681,458...17,811,453
Ensembl chr17:17,681,458...17,811,453
G
RANBP6
RAN binding protein 6
increases expression
ISO
Phenytoin results in increased expression of RANBP6 mRNA
CTD
PMID:20345932
NCBI chr 9:6,011,025...6,015,624
Ensembl chr 9:6,011,025...6,015,625
G
RAPGEF4
Rap guanine nucleotide exchange factor 4
increases expression
ISO
Phenytoin results in increased expression of RAPGEF4 mRNA
CTD
PMID:20345932
NCBI chr 2:172,735,318...173,052,893
Ensembl chr 2:172,735,274...173,052,893
G
RARA
retinoic acid receptor alpha
increases expression decreases expression
ISO
Phenytoin results in increased expression of RARA mRNA Phenytoin results in decreased expression of RARA mRNA
CTD
PMID:9118846 PMID:9988880
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
G
RARB
retinoic acid receptor beta
increases expression
ISO
Phenytoin results in increased expression of RARB mRNA
CTD
PMID:9988880
NCBI chr 3:24,829,321...25,597,932
Ensembl chr 3:24,687,887...25,597,932
G
RARG
retinoic acid receptor gamma
increases expression
ISO
Phenytoin results in increased expression of RARG mRNA
CTD
PMID:9988880
NCBI chr12:53,210,569...53,232,209
Ensembl chr12:53,210,567...53,232,980
G
RBM12
RNA binding motif protein 12
increases expression
ISO
Phenytoin results in increased expression of RBM12 mRNA
CTD
PMID:20345932
NCBI chr20:35,648,925...35,664,900
Ensembl chr20:35,648,925...35,664,956
G
RBM3
RNA binding motif protein 3
increases expression
ISO
Phenytoin results in increased expression of RBM3 mRNA
CTD
PMID:20345932
NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,449...48,581,162
G
RBM34
RNA binding motif protein 34
increases expression
ISO
Phenytoin results in increased expression of RBM34 mRNA
CTD
PMID:20345932
NCBI chr 1:235,131,183...235,161,250
Ensembl chr 1:235,131,183...235,161,283
G
RBP2
retinol binding protein 2
increases expression
ISO
Phenytoin results in increased expression of RBP2 mRNA
CTD
PMID:9118846
NCBI chr 3:139,452,884...139,476,516
Ensembl chr 3:139,452,884...139,480,747
G
RDH14
retinol dehydrogenase 14
increases expression
ISO
Phenytoin results in increased expression of RDH14 mRNA
CTD
PMID:20345932
NCBI chr 2:18,554,723...18,560,653
Ensembl chr 2:18,554,723...18,560,679
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions increases activity
EXP ISO
Phenytoin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased localization of and results in increased activity of RELA protein] Phenytoin results in increased activity of RELA protein
CTD
PMID:10700573 PMID:15322231
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RHOA
ras homolog family member A
decreases expression
ISO
Phenytoin results in decreased expression of RHOA mRNA
CTD
PMID:15136057
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RIOK2
RIO kinase 2
increases expression
ISO
Phenytoin results in increased expression of RIOK2 mRNA
CTD
PMID:20345932
NCBI chr 5:97,160,867...97,183,247
Ensembl chr 5:97,160,867...97,183,247
G
RNASEH1
ribonuclease H1
decreases expression
ISO
Phenytoin results in decreased expression of RNASEH1 mRNA
CTD
PMID:20345932
NCBI chr 2:3,531,813...3,558,333
Ensembl chr 2:3,541,430...3,558,333
G
RND1
Rho family GTPase 1
increases expression
ISO
Phenytoin results in increased expression of RND1 mRNA
CTD
PMID:20345932
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
G
RNF115
ring finger protein 115
increases expression
ISO
Phenytoin results in increased expression of RNF115 mRNA
CTD
PMID:20345932
NCBI chr 1:145,738,868...145,824,095
Ensembl chr 1:145,738,868...145,824,095
G
RPE
ribulose-5-phosphate-3-epimerase
increases expression
ISO
Phenytoin results in increased expression of RPE mRNA
CTD
PMID:20345932
NCBI chr 2:210,002,638...210,022,260
Ensembl chr 2:210,002,565...210,022,260
G
RPL28
ribosomal protein L28
increases expression
EXP
Phenytoin results in increased expression of RPL28 mRNA
CTD
PMID:14741686
NCBI chr19:55,385,932...55,403,342
Ensembl chr19:55,385,932...55,403,250
G
RPS6KA3
ribosomal protein S6 kinase A3
increases expression
ISO
Phenytoin results in increased expression of RPS6KA3 mRNA
CTD
PMID:20345932
NCBI chr X:20,149,911...20,267,097
Ensembl chr X:20,149,911...20,267,519
G
RPSA
ribosomal protein SA
increases expression
EXP
Phenytoin results in increased expression of RPSA mRNA
CTD
PMID:14741686
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
G
RSRC1
arginine and serine rich coiled-coil 1
decreases expression
ISO
Phenytoin results in decreased expression of RSRC1 mRNA
CTD
PMID:20345932
NCBI chr 3:158,110,089...158,545,730
Ensembl chr 3:158,105,855...158,545,730
G
RYR2
ryanodine receptor 2
increases expression
ISO
Phenytoin results in increased expression of RYR2 mRNA
CTD
PMID:20345932
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
G
S100A10
S100 calcium binding protein A10
increases expression
EXP
Phenytoin results in increased expression of S100A10 mRNA
CTD
PMID:14741686
NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
G
S100A4
S100 calcium binding protein A4
increases expression
EXP
Phenytoin results in increased expression of S100A4 mRNA
CTD
PMID:14741686
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
G
S100A8
S100 calcium binding protein A8
multiple interactions
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of S100A8 mRNA
CTD
PMID:23986454
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
multiple interactions increases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of S100A9 mRNA Phenytoin results in increased expression of S100A9 mRNA
CTD
PMID:23986454
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SART3
spliceosome associated factor 3, U4/U6 recycling protein
increases expression
ISO
Phenytoin results in increased expression of SART3 mRNA
CTD
PMID:20345932
NCBI chr12:108,522,214...108,561,173
Ensembl chr12:108,522,214...108,561,400
G
SC5D
sterol-C5-desaturase
increases expression
EXP
Phenytoin results in increased expression of SC5D mRNA
CTD
PMID:14741686
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
G
SCAF1
SR-related CTD associated factor 1
increases expression
ISO
Phenytoin results in increased expression of SCAF1 mRNA
CTD
PMID:20345932
NCBI chr19:49,640,465...49,658,642
Ensembl chr19:49,642,209...49,658,642
G
SCARB1
scavenger receptor class B member 1
decreases expression
ISO
Phenytoin results in decreased expression of SCARB1 mRNA
CTD
PMID:15136057
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SCN1A
sodium voltage-gated channel alpha subunit 1
affects response to substance
EXP
SCN1A gene polymorphism affects the susceptibility to Phenytoin; SCN1A protein affects the susceptibility to Phenytoin
CTD
PMID:15805193 PMID:17001291
NCBI chr 2:165,984,641...166,149,161
Ensembl chr 2:165,984,641...166,149,214
G
SCN1B
sodium voltage-gated channel beta subunit 1
affects binding decreases response to substance multiple interactions
EXP
Phenytoin binds to [SCN1B protein binds to SCN3A protein] SCN1B protein mutant form results in decreased susceptibility to Phenytoin Phenytoin results in decreased activity of [SCN1B protein binds to SCN3A protein]
CTD
PMID:15922564
NCBI chr19:35,030,470...35,040,449
Ensembl chr19:35,030,470...35,040,449
G
SCN2A
sodium voltage-gated channel alpha subunit 2
decreases activity
EXP
Phenytoin results in decreased activity of SCN2A protein
CTD
PMID:11212204
NCBI chr 2:165,239,414...165,392,304
Ensembl chr 2:165,194,993...165,392,310
G
SCN3A
sodium voltage-gated channel alpha subunit 3
multiple interactions affects binding
EXP
Phenytoin results in decreased activity of [SCN1B protein binds to SCN3A protein] Phenytoin binds to [SCN1B protein binds to SCN3A protein]
CTD
PMID:15922564
NCBI chr 2:165,087,526...165,204,050
Ensembl chr 2:165,087,526...165,204,050
G
SDC4
syndecan 4
decreases expression
ISO
Phenytoin results in decreased expression of SDC4 mRNA
CTD
PMID:15136057
NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424
G
SELE
selectin E
multiple interactions
EXP
[clobazam co-treated with Phenytoin] results in increased expression of SELE protein
CTD
PMID:16376047
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
SENP7
SUMO specific peptidase 7
increases expression
ISO
Phenytoin results in increased expression of SENP7 mRNA
CTD
PMID:20345932
NCBI chr 3:101,324,205...101,513,212
Ensembl chr 3:101,324,205...101,513,241
G
SERPINC1
serpin family C member 1
multiple interactions
EXP
[clobazam co-treated with Phenytoin] results in increased expression of [F2 protein binds to SERPINC1 protein]
CTD
PMID:16376047
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of SERPINE1 mRNA
CTD
PMID:21224054
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SH3YL1
SH3 and SYLF domain containing 1
increases expression
ISO
Phenytoin results in increased expression of SH3YL1 mRNA
CTD
PMID:20345932
NCBI chr 2:218,136...264,824
Ensembl chr 2:217,730...266,398
G
SHH
sonic hedgehog signaling molecule
increases expression
ISO
Phenytoin results in increased expression of SHH mRNA
CTD
PMID:26272751
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SIAH1
siah E3 ubiquitin protein ligase 1
increases expression
ISO
Phenytoin results in increased expression of SIAH1A mRNA
CTD
PMID:20345932
NCBI chr16:48,360,531...48,387,246
Ensembl chr16:48,356,364...48,448,402
G
SIPA1L1
signal induced proliferation associated 1 like 1
increases expression
ISO
Phenytoin results in increased expression of SIPA1L1 mRNA
CTD
PMID:20345932
NCBI chr14:71,320,476...71,741,209
Ensembl chr14:71,320,449...71,741,229
G
SLC22A7
solute carrier family 22 member 7
decreases expression
ISO
Phenytoin results in decreased expression of SLC22A7 mRNA
CTD
PMID:17381134
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SLC4A3
solute carrier family 4 member 3
increases expression
ISO
Phenytoin results in increased expression of SLC4A3 mRNA
CTD
PMID:20345932
NCBI chr 2:219,627,630...219,641,971
Ensembl chr 2:219,627,394...219,641,980
G
SMARCA1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
increases expression
ISO
Phenytoin results in increased expression of SMARCA1 mRNA
CTD
PMID:20345932
NCBI chr X:129,446,506...129,523,490
Ensembl chr X:129,446,501...129,523,500
G
SMARCA5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
increases expression
ISO
Phenytoin results in increased expression of SMARCA5 mRNA
CTD
PMID:20345932
NCBI chr 4:143,513,702...143,557,486
Ensembl chr 4:143,513,702...143,557,486
G
SMC2
structural maintenance of chromosomes 2
increases expression
ISO
Phenytoin results in increased expression of SMC2 mRNA
CTD
PMID:20345932
NCBI chr 9:104,088,263...104,141,419
Ensembl chr 9:104,094,260...104,141,419
G
SMC3
structural maintenance of chromosomes 3
increases expression
EXP
Phenytoin results in increased expression of SMC3 mRNA
CTD
PMID:14741686
NCBI chr10:110,567,695...110,606,048
Ensembl chr10:110,567,684...110,606,048
G
SMC5
structural maintenance of chromosomes 5
increases expression
ISO
Phenytoin results in increased expression of SMC5 mRNA
CTD
PMID:20345932
NCBI chr 9:70,258,978...70,354,873
Ensembl chr 9:70,258,978...70,354,873
G
SNX2
sorting nexin 2
increases expression
ISO
Phenytoin results in increased expression of SNX2 mRNA
CTD
PMID:20345932
NCBI chr 5:122,774,996...122,834,543
Ensembl chr 5:122,775,079...122,834,543
G
SP3
Sp3 transcription factor
increases expression
EXP
Phenytoin results in increased expression of SP3 mRNA
CTD
PMID:14741686
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
G
ST13
ST13 Hsp70 interacting protein
increases expression
ISO
Phenytoin results in increased expression of ST13 mRNA
CTD
PMID:17381134
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
STAT4
signal transducer and activator of transcription 4
decreases expression
EXP
Phenytoin results in decreased expression of STAT4 mRNA
CTD
PMID:14741686
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
G
SULT1A1
sulfotransferase family 1A member 1
decreases expression
ISO
Phenytoin results in decreased expression of SULT1A1 mRNA
CTD
PMID:9566755 PMID:17381134
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
G
SULT2A1
sulfotransferase family 2A member 1
decreases expression
ISO
Phenytoin results in decreased expression of SULT2A1 mRNA
CTD
PMID:9566755
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
G
SYN1
synapsin I
decreases expression multiple interactions
ISO
Phenytoin results in decreased expression of SYN1 mRNA Thyroxine inhibits the reaction [Phenytoin results in decreased expression of SYN1 mRNA]
CTD
PMID:27413119
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
G
SYP
synaptophysin
decreases expression multiple interactions
ISO
Phenytoin results in decreased expression of SYP mRNA Thyroxine inhibits the reaction [Phenytoin results in decreased expression of SYP mRNA]
CTD
PMID:27413119
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
G
SYPL1
synaptophysin like 1
increases expression
ISO
Phenytoin results in increased expression of SYPL1 mRNA
CTD
PMID:20345932
NCBI chr 7:106,090,505...106,112,576
Ensembl chr 7:106,090,505...106,112,589
G
TAF9B
TATA-box binding protein associated factor 9b
increases expression
ISO
Phenytoin results in increased expression of TAF9B mRNA
CTD
PMID:20345932
NCBI chr X:78,129,748...78,139,650
Ensembl chr X:78,129,748...78,139,650
G
TBX21
T-box transcription factor 21
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of TBX21 mRNA Phenytoin results in decreased expression of TBX21 mRNA
CTD
PMID:23986454
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
TCEAL1
transcription elongation factor A like 1
increases expression
ISO
Phenytoin results in increased expression of TCEAL1 mRNA
CTD
PMID:20345932
NCBI chr X:103,628,716...103,630,953
Ensembl chr X:103,628,704...103,630,953
G
TCF15
transcription factor 15
decreases expression
EXP
Phenytoin results in decreased expression of TCF15 mRNA
CTD
PMID:31711903
NCBI chr20:604,257...610,309
Ensembl chr20:604,257...610,309
G
TERF1
telomeric repeat binding factor 1
increases expression
ISO
Phenytoin results in increased expression of TERF1 mRNA
CTD
PMID:20345932
NCBI chr 8:73,008,864...73,048,123
Ensembl chr 8:73,008,856...73,048,123
G
TGFA
transforming growth factor alpha
increases expression
ISO
Phenytoin results in increased expression of TGFA mRNA
CTD
PMID:9988880
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
G
TGFB1
transforming growth factor beta 1
increases expression decreases expression
ISO
Phenytoin results in increased expression of TGFB1 mRNA Phenytoin results in decreased expression of TGFB1 mRNA
CTD
PMID:7841657 PMID:9988880 PMID:16141649
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB2
transforming growth factor beta 2
decreases expression
ISO
Phenytoin results in decreased expression of TGFB2 mRNA
CTD
PMID:9118846
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFB3
transforming growth factor beta 3
increases expression
EXP
Phenytoin results in increased expression of TGFB3 mRNA
CTD
PMID:14741686
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
THOC6
THO complex subunit 6
decreases expression
ISO
Phenytoin results in decreased expression of THOC6 mRNA
CTD
PMID:20345932
NCBI chr16:3,024,035...3,027,750
Ensembl chr16:3,024,027...3,027,755
G
TIMP1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Phenytoin results in increased expression of TIMP1 mRNA; Phenytoin results in increased expression of TIMP1 protein
CTD
PMID:10914799 PMID:14741686 PMID:15948689
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TKT
transketolase
increases expression
ISO
Phenytoin results in increased expression of TKT mRNA
CTD
PMID:17381134
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TLR2
toll like receptor 2
multiple interactions increases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in increased expression of TLR2 mRNA Phenytoin results in increased expression of TLR2 mRNA
CTD
PMID:23986454
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of TLR4 mRNA Phenytoin results in decreased expression of TLR4 mRNA
CTD
PMID:23986454
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR9
toll like receptor 9
multiple interactions decreases expression
ISO
[Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of TLR9 mRNA Phenytoin results in decreased expression of TLR9 mRNA
CTD
PMID:23986454
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TNF
tumor necrosis factor
increases expression
EXP
Phenytoin results in increased expression of TNF mRNA
CTD
PMID:14741686
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFSF10
TNF superfamily member 10
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA
CTD
PMID:21224054
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TP53
tumor protein p53
increases expression
EXP
Phenytoin results in increased expression of TP53 mRNA
CTD
PMID:11134551
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TP53BP2
tumor protein p53 binding protein 2
increases expression
ISO
Phenytoin results in increased expression of TRP53BP2 mRNA
CTD
PMID:20345932
NCBI chr 1:223,779,893...223,845,947
Ensembl chr 1:223,779,893...223,845,954
G
TRADD
TNFRSF1A associated via death domain
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TRADD mRNA
CTD
PMID:21224054
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
G
TRMT10B
tRNA methyltransferase 10B
increases expression
ISO
Phenytoin results in increased expression of TRMT10B mRNA
CTD
PMID:20345932
NCBI chr 9:37,752,901...37,778,972
Ensembl chr 9:37,753,803...37,778,972
G
TUT4
terminal uridylyl transferase 4
increases expression
ISO
Phenytoin results in increased expression of TUT4 mRNA
CTD
PMID:20345932
NCBI chr 1:52,423,275...52,553,463
Ensembl chr 1:52,408,282...52,553,487
G
TXNRD1
thioredoxin reductase 1
increases expression
ISO
Phenytoin results in increased expression of TXNRD1 mRNA
CTD
PMID:17381134
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UBE2D2
ubiquitin conjugating enzyme E2 D2
increases expression
ISO
Phenytoin results in increased expression of UBE2D2 mRNA
CTD
PMID:20345932
NCBI chr 5:139,526,240...139,628,434
Ensembl chr 5:139,526,431...139,628,434
G
UBL5
ubiquitin like 5
decreases expression
ISO
Phenytoin results in decreased expression of UBL5 mRNA
CTD
PMID:20345932
NCBI chr19:9,827,918...9,830,115
Ensembl chr19:9,827,892...9,830,115
G
UBR1
ubiquitin protein ligase E3 component n-recognin 1
increases expression
ISO
Phenytoin results in increased expression of UBR1 mRNA
CTD
PMID:20345932
NCBI chr15:42,942,897...43,106,038
Ensembl chr15:42,942,897...43,106,113
G
UGDH
UDP-glucose 6-dehydrogenase
decreases expression
ISO
Phenytoin results in decreased expression of UGDH mRNA
CTD
PMID:17381134
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
affects expression increases activity multiple interactions increases expression
EXP ISO
Phenytoin affects the expression of UGT1A1 mRNA Phenytoin results in increased activity of UGT1A1 protein Phenytoin results in increased expression of and results in increased activity of UGT1A1 protein Phenytoin results in increased expression of UGT1A1 mRNA Phenytoin results in increased expression of UGT1A1 mRNA; Phenytoin results in increased expression of UGT1A1 protein
CTD
PMID:10421657 PMID:15849716 PMID:17381134 PMID:27413119
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
Phenytoin results in increased expression of UGT1A6 mRNA
CTD
PMID:17381134
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases expression
ISO
Phenytoin results in increased expression of UGT2B1 mRNA
CTD
PMID:17381134
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
UNCX
UNC homeobox
decreases expression
EXP
Phenytoin results in decreased expression of UNCX mRNA
CTD
PMID:31711903
NCBI chr 7:1,232,872...1,237,326
Ensembl chr 7:1,232,872...1,237,326
G
UNG
uracil DNA glycosylase
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of UNG mRNA
CTD
PMID:21224054
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
G
VARS2
valyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
Phenytoin results in increased expression of VARS2 mRNA
CTD
PMID:20345932
NCBI chr 6:30,914,238...30,926,459
Ensembl chr 6:30,914,205...30,926,459
G
VCAN
versican
increases expression
EXP
Phenytoin results in increased expression of VCAN mRNA
CTD
PMID:14741686
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
G
VEGFB
vascular endothelial growth factor B
decreases expression
EXP
Phenytoin results in decreased expression of VEGFB mRNA
CTD
PMID:14741686
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VIM
vimentin
increases expression
EXP
Phenytoin results in increased expression of VIM mRNA
CTD
PMID:14741686
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
WNT1
Wnt family member 1
decreases expression
ISO
Phenytoin results in decreased expression of WNT1 mRNA
CTD
PMID:7841657
NCBI chr12:48,978,322...48,982,620
Ensembl chr12:48,978,322...48,982,620
G
WNT3
Wnt family member 3
decreases expression
ISO
Phenytoin results in decreased expression of WNT3 mRNA
CTD
PMID:26272751
NCBI chr17:46,762,506...46,818,692
Ensembl chr17:46,762,506...46,833,154
G
WNT5A
Wnt family member 5A
increases expression
EXP
Phenytoin results in increased expression of WNT5A mRNA
CTD
PMID:31711903
NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539
G
XRCC4
X-ray repair cross complementing 4
multiple interactions
ISO
[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of XRCC4 mRNA
CTD
PMID:21224054
NCBI chr 5:83,077,547...83,374,473
Ensembl chr 5:83,077,498...83,353,787
G
YME1L1
YME1 like 1 ATPase
increases expression
ISO
Phenytoin results in increased expression of YME1L1 mRNA
CTD
PMID:20345932
NCBI chr10:27,110,111...27,154,384
Ensembl chr10:27,110,111...27,155,266
G
ZAP70
zeta chain of T cell receptor associated protein kinase 70
decreases expression
ISO
Phenytoin results in decreased expression of ZAP70 mRNA
CTD
PMID:15136057
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,739,862
G
ZNF131
zinc finger protein 131
increases expression
ISO
Phenytoin results in increased expression of ZFP131 mRNA
CTD
PMID:20345932
NCBI chr 5:43,120,914...43,176,324
Ensembl chr 5:43,065,176...43,192,021
G
ZNF503
zinc finger protein 503
increases expression
ISO
Phenytoin results in increased expression of ZFP503 mRNA
CTD
PMID:20345932
NCBI chr10:75,279,725...75,401,916
Ensembl chr10:75,397,830...75,401,764
G
ZNF638
zinc finger protein 638
increases expression
ISO
Phenytoin results in increased expression of ZFP638 mRNA
CTD
PMID:20345932
NCBI chr 2:71,331,782...71,435,061
Ensembl chr 2:71,276,561...71,435,069
G
ZSCAN21
zinc finger and SCAN domain containing 21
increases expression
ISO
Phenytoin results in increased expression of ZSCAN21 mRNA
CTD
PMID:20345932
NCBI chr 7:100,049,774...100,065,040
Ensembl chr 7:100,049,774...100,065,040
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all